Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma

NCT01621880 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
Adverse Effect of Radiation Therapy
Brain Necrosis

Interventions

DRUG: bevacizumab
DRUG: Corticosteroid

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University